CDCrel-1 Activators comprise a range of chemical compounds that potentially enhance the functional activity of CDCrel-1, a septin protein implicated in diverse cellular processes such as vesicle trafficking, cytokinesis, and cytoskeletal organization. Compounds like Phosphatidylinositol 4,5-bisphosphate (PIP2) and GTP are fundamental to the polymerization and GTPase activity of CDCrel-1, thereby directly influencing its structural and regulatory roles within the cell. Forskolin, through the elevation of cAMP, may indirectly promote CDCrel-1 activity by facilitating the phosphorylation events that govern its interactions with other cell cycle regulators. Similarly, ionomycin can lead to enhanced CDCrel-1 activity via calcium-dependent signaling pathways that intersect with septin functions. Actin and microtubule dynamics are essential for CDCrel-1-mediated processes, and stabilizing agents such as Phalloidin and Paclitaxel, along with destabilizers like Nocodazole and Cytochalasin D, offer unique ways to modulate CDCrel-1 activity by altering the cytoskeletal elements that septins associate with. Phalloidin, by reinforcing actin filaments, and Paclitaxel, by stabilizing microtubules, support the structural framework necessary for CDCrel-1 to exert its effects on cell division and intracellular transport. Conversely, Nocodazole and Cytochalasin D induce cytoskeletal stress responses that may activate CDCrel-1 as part of the cellular adaptation to maintain cytoskeletal integrity.
The activity of CDCrel-1 is further influenced by the local cellular environment, with compounds such as Guanosine 5'-O-(3-Thio)triphosphate (GTPγS) and Jasplakinolide promoting a conducive setting for its action. GTPγS, a non-hydrolyzable analogue of GTP, ensures a consistent supply of GTP-bound CDCrel-1, essential for its function, while Jasplakinolide's effect on F-actin may facilitate the proper organization of septin filaments, crucial for CDCrel-1's role in cellular dynamics. Diacylglycerol (DAG) and Sphingosine-1-phosphate (S1P) engage in signaling cascades that can enhance CDCrel-1's involvement in vesicle fusion and cytokinesis, respectively. DAG's activation of Protein Kinase C (PKC) could lead to phosphorylation events that enhance CDCrel-1's interactions with other proteins, while S1P's receptor-mediated signaling pathways provide a broad platform for CDCrel-1 to integrate into cellular processes that emphasize its importance in maintaining cellular architecture and facilitating cell division. Collectively, these CDCrel-1 Activators support and enhance the protein's essential functions without directly increasing its expression or relying on direct activation mechanisms.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin elevates cAMP levels, which could enhance CDCrel-1 activity by promoting its interaction with kinases involved in cell cycle regulation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium, which may indirectly activate CDCrel-1 through calcium-dependent kinases that interact with septins. | ||||||
Phalloidin | 17466-45-4 | sc-202763 | 1 mg | $234.00 | 33 | |
Phalloidin stabilizes actin filaments and could enhance CDCrel-1 activity by facilitating its role in actin-septin complex formations. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules, potentially enhancing CDCrel-1's role in microtubule-dependent processes such as vesicle trafficking. | ||||||
Guanosine 5′-O-(3-thiotriphosphate) tetralithium salt | 94825-44-2 | sc-202639 | 10 mg | $465.00 | ||
GTPγS is a non-hydrolyzable GTP analogue that can activate CDCrel-1 by binding to it and promoting its GTPase activity in a stable manner. | ||||||
Jasplakinolide | 102396-24-7 | sc-202191 sc-202191A | 50 µg 100 µg | $184.00 $305.00 | 59 | |
Jasplakinolide stabilizes F-actin and may enhance CDCrel-1 activity by affecting the septin filament organization and dynamics. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubules, which may lead to activation of CDCrel-1 as part of the cellular response to microtubule depolymerization. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $165.00 $486.00 | 64 | |
Cytochalasin D disrupts actin polymerization, potentially activating CDCrel-1 by triggering compensatory mechanisms in cytoskeletal maintenance. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P binds to its receptors to activate signaling cascades that could indirectly increase the activity of CDCrel-1 in cellular processes like cytokinesis. | ||||||